Personalized Brain Activity-Based Pain Management Systems with Real-Time Feedback

The inventive concept enhances pain management by incorporating machine learning, real-time patient feedback, and advanced neural interface technologies to optimize neuromodulation therapy settings for individual patients, improving treatment efficacy and efficiency.

The original patent, 'Pain management based on brain activity monitoring', provided a foundation for using brain activity signals to guide neuromodulation therapy. However, it had limitations in terms of optimizing therapy settings for individual patients and incorporating real-time feedback. The new inventive concept addresses these limitations by integrating machine learning, advanced neural interface technologies, and real-time patient feedback to create a more personalized and adaptive pain management system.

The new inventive concept consists of a neural interface module to receive brain activity signals, a processing module to calculate a brain activity score, and a neuromodulation module to deliver therapy settings based on the score. Additionally, the system incorporates a machine learning module to optimize the therapy settings based on patient feedback, a wearable EEG sensor for convenient signal acquisition, and a mobile application to provide real-time patient feedback. The system can also adapt to individual patients' brain activity patterns over time, ensuring a more personalized treatment approach.

The new inventive concept introduces the novel combination of machine learning, real-time patient feedback, and advanced neural interface technologies to optimize neuromodulation therapy settings for individual patients. This integration of components provides a non-obvious solution to the limitations of the original patent, resulting in a more efficient and effective pain management system.

Alternative embodiments of the inventive concept could include using different types of neural interface technologies, such as magnetoencephalography (MEG) or functional near-infrared spectroscopy (fNIRS), or incorporating additional sensors to monitor other physiological parameters. Variations could also include using different machine learning algorithms or incorporating additional feedback mechanisms, such as electromyography (EMG) or electrooculography (EOG) signals.

The inventive concept has significant commercial potential in the pain management market, particularly in the areas of chronic pain treatment and personalized medicine. The system's ability to provide real-time feedback and adapt to individual patients' needs could lead to increased treatment efficacy and patient satisfaction, making it an attractive solution for healthcare providers and patients alike.